Skip to content

English Language Version of the Educational Module Resource (EMR)

The EMR consists of 21 lectures, accompanying notes for the lecturer and direct links to the references and videos; it is intended to be a resource that can be used by a lecturer in order to develop one or more lectures, seminars, role-plays or other teaching aids suitable for the course he or she is presenting. We would like to emphasise that the educational module resource is not a Teaching Module rather it is a 'Module Resource'. Conscious that there is no one-size-fits-all approach, our educational module resource is designed to be 'modified and tailored in order to fit the requirements of different local educational contexts'. Please read '1. Introduction' first.

1. EMR Introduction and Overview

This section provides an overview of the lectures in the English version of the Education Module Resource (EMR).

1. Introduction and Overview

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

2. The Threat of Biological Warfare (BW) and Biological Terrorism (BT) and the International Prohibition Regime

This section provides material on the threat of biological warfare (BW) and biological terrorism (BT) and the international prohibition regime. Material can be accessed in PowerPoint (PPT) or PDF format. Two background briefing papers have been developed to support this section of the EMR and are available below.

Background Brief 1

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

Background Brief 2

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

Lecture Number & Title

2. BW from Antiquity to WWI

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

3. The Dual-Use Dilemma and the Responsibilities of Life Scientists

This section provides material on the dual-use dilemma and the responsibilities of life scientists.

3. BW from WWI to WWII

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

4. BW during the Cold War

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

5. Impact of Biological Warfare Agents

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

6. Assimilation of BW

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

7. The International Legal Agreements

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

8. Strengthening the BTWC 1980 -2008

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

9. The 2003-2005 Intersessional Process

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

10. The 2007-2010 New Intersessional Process

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

11. Bioethics Methodology (in Japanese)

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

12. Obligations Derived from the BTWC

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

13. The Growth of Dual-Use Bioethics

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

14. Dual-Use: The Fink Report

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

Background Brief No. 3 Dual-Use Research

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

15. Dual-Use Examples

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

15b. Appl. Dual-Use Examples

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

16. The Lemon-Relman Report

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

16b. Appl. The Lemon-Relman Report (in Japanese)

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

17. Weapons Targeted at Nervous System

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

17b. Appl. Weapons Targeted at Nervous System

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

4. National Implementation of the BTWC

This section provides material on the National implementation of the BTWC. Material can be accessed in PowerPoint (PPT) or PDF format. A background briefing paper has been developed to support this section of the EMR and is available below.

Background Brief No. 4 National Implementation

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

18. Regulation of the Life Sciences

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

19. International Regulation of Biotechnology

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

20. National Implementation Legislation

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

20. National Implementation Legislation

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.

21. The Web of Prevention

If you require this information in an alternative format, please contact our team. You can also read our Website Accessibility Statement.